Literature DB >> 24359899

Stopping the swinging pendulum of postnatal corticosteroid use.

Sara B Demauro1, Kevin Dysart1, Haresh Kirpalani2.   

Abstract

Entities:  

Keywords:  AAP; American Academy of Pediatrics; BPD; Bronchopulmonary dysplasia; CP; Cerebral palsy; DART; Dexamethasone: A Randomized Trial; Eunice Kennedy Shriver National Institute of Child Health and Human Development; NICHD; NRN; Neonatal Research Network

Mesh：

Substances：

Year:  2014        PMID： 24359899      PMCID： PMC4339057          DOI： 10.1016/j.jpeds.2013.10.020

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  37 in total

1.  Postnatal steroids: a dilemma for the neonatologist.

Authors:  H L Halliday
Journal:  Acta Paediatr       Date:  2001-02       Impact factor: 2.299

2.  Hazards of systemic steroids for ventilator-dependent preterm infants: what would a parent want?

Authors:  K J Barrington
Journal:  CMAJ       Date:  2001-07-10       Impact factor: 8.262

3.  Meta-analysis of postnatal steroid use challenged.

Authors:  Catherine Taylor; Prakeshkumar S Shah; Michael S Dunn
Journal:  Pediatrics       Date:  2002-04       Impact factor: 7.124

4.  Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.

Authors: 
Journal:  Pediatrics       Date:  2002-02       Impact factor: 7.124

5.  Effect of AAP statement regarding postnatal corticosteroids on ongoing and future randomized, controlled trials.

Authors:  Lex Doyle; Peter Davis; Colin Morley
Journal:  Pediatrics       Date:  2002-11       Impact factor: 7.124

6.  Postnatal corticosteroids for preterm infants--do what we say, not what we do.

Authors:  Alan H Jobe
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

7.  Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease.

Authors:  B P Murphy; T E Inder; P S Huppi; S Warfield; G P Zientara; R Kikinis; F A Jolesz; J J Volpe
Journal:  Pediatrics       Date:  2001-02       Impact factor: 7.124

8.  Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms.

Authors:  Barbara Schmidt; Elizabeth V Asztalos; Robin S Roberts; Charlene M T Robertson; Reginald S Sauve; Michael F Whitfield
Journal:  JAMA       Date:  2003-03-05       Impact factor: 56.272

Review 9.  Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.

Authors:  H L Halliday; R A Ehrenkranz; L W Doyle
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 10.  Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.

Authors:  H L Halliday; R A Ehrenkranz; L W Doyle
Journal:  Cochrane Database Syst Rev       Date:  2003
View more
  3 in total

1.  Neonatal Dexamethasone Treatment Suppresses Hippocampal Estrogen Receptor α Expression in Adolescent Female Rats.

Authors:  Hui-Fang Chiu; Michael W Y Chan; Chiung-Yin Cheng; Jian-Liang Chou; Jora Meng-Ju Lin; Yi-Ling Yang; Kwok-Tung Lu
Journal:  Mol Neurobiol       Date:  2018-07-13       Impact factor: 5.590

2.  Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis of Preclinical Studies.

Authors:  Sajit Augustine; Marc T Avey; Brittany Harrison; Tiffany Locke; Mona Ghannad; David Moher; Bernard Thébaud
Journal:  Stem Cells Transl Med       Date:  2017-10-17       Impact factor: 6.940

3.  Are all stem cells equal? Systematic review, evidence map, and meta-analyses of preclinical stem cell-based therapies for bronchopulmonary dysplasia.

Authors:  Sajit Augustine; Wei Cheng; Marc T Avey; Monica L Chan; Srinivasa Murthy Chitra Lingappa; Brian Hutton; Bernard Thébaud
Journal:  Stem Cells Transl Med       Date:  2019-11-20       Impact factor: 6.940
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.